Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Second Edition BOGP (0)
Australie (1)
Other
Musculoskeletal/Multiple Sclerosis (MS) (1)
Regulatory Body (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Representativeness of stakeholders
Regulatory Review & Approval